104 related articles for article (PubMed ID: 27531741)
1. Metformin for endometrial hyperplasia: a Cochrane protocol.
Clement NS; Oliver TR; Shiwani H; Saner JR; Mulvaney CA; Atiomo W
BMJ Open; 2016 Aug; 6(8):e013385. PubMed ID: 27531741
[TBL] [Abstract][Full Text] [Related]
2. Metformin for endometrial hyperplasia.
Clement NS; Oliver TR; Shiwani H; Sanner JR; Mulvaney CA; Atiomo W
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012214. PubMed ID: 29077194
[TBL] [Abstract][Full Text] [Related]
3. Metformin for endometrial hyperplasia.
Shiwani H; Clement NS; Daniels JP; Atiomo W
Cochrane Database Syst Rev; 2024 May; 5(5):CD012214. PubMed ID: 38695827
[TBL] [Abstract][Full Text] [Related]
4. Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.
Fernandez-Montoli ME; Sabadell J; Contreras-Perez NA
Adv Ther; 2021 May; 38(5):2717-2731. PubMed ID: 33830463
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin on endometrial cancer: Systematic review and meta-analysis.
Meireles CG; Pereira SA; Valadares LP; Rêgo DF; Simeoni LA; Guerra ENS; Lofrano-Porto A
Gynecol Oncol; 2017 Oct; 147(1):167-180. PubMed ID: 28760367
[TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
Mitsuhashi A; Kawasaki Y; Hori M; Fujiwara T; Hanaoka H; Shozu M
BMJ Open; 2020 Feb; 10(2):e035416. PubMed ID: 32114477
[TBL] [Abstract][Full Text] [Related]
7. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
Shen ZQ; Zhu HT; Lin JF
Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
[TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic approaches for the fertility-sparing treatment of endometrial cancer.
Mitsuhashi A; Shozu M
J Obstet Gynaecol Res; 2020 Feb; 46(2):215-222. PubMed ID: 32017321
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effect of metformin on the endometrium--a clinical trial.
Tabrizi AD; Melli MS; Foroughi M; Ghojazadeh M; Bidadi S
Asian Pac J Cancer Prev; 2014; 15(23):10067-70. PubMed ID: 25556427
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
Abu Hashim H; Ghayaty E; El Rakhawy M
Am J Obstet Gynecol; 2015 Oct; 213(4):469-78. PubMed ID: 25797236
[TBL] [Abstract][Full Text] [Related]
12. Topical cyclosporine for atopic keratoconjunctivitis.
González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients.
Mitsuhashi A; Habu Y; Kobayashi T; Kawarai Y; Ishikawa H; Usui H; Shozu M
J Gynecol Oncol; 2019 Nov; 30(6):e90. PubMed ID: 31576686
[TBL] [Abstract][Full Text] [Related]
14. Psychological, social and welfare interventions for psychological health and well-being of torture survivors.
Patel N; Kellezi B; Williams AC
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009317. PubMed ID: 25386846
[TBL] [Abstract][Full Text] [Related]
15. Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis.
Shao F; Li Y; Zhao Y
Front Endocrinol (Lausanne); 2023; 14():1139858. PubMed ID: 37415671
[TBL] [Abstract][Full Text] [Related]
16. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
[TBL] [Abstract][Full Text] [Related]
17. A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
Sharifzadeh F; Aminimoghaddam S; Kashanian M; Fazaeli M; Sheikhansari N
Gynecol Endocrinol; 2017 Feb; 33(2):152-155. PubMed ID: 27690687
[TBL] [Abstract][Full Text] [Related]
18. Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent.
Session DR; Kalli KR; Tummon IS; Damario MA; Dumesic DA
Gynecol Endocrinol; 2003 Oct; 17(5):405-7. PubMed ID: 14710588
[TBL] [Abstract][Full Text] [Related]
19. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
[TBL] [Abstract][Full Text] [Related]
20. Adverse Long-term Metabolic and Endometrial Consequences in Women with Polycystic Ovarian Syndrome: A Report of Two Cases.
Mahmoud SA; Zhang L; Jia C; Zang H
J Reprod Med; 2016; 61(5-6):302-5. PubMed ID: 27424378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]